Hec Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HEC PHARM, and what generic and branded alternatives to HEC PHARM drugs are available?
HEC PHARM has seven approved drugs.
Summary for Hec Pharm
US Patents: | 0 |
Tradenames: | 7 |
Ingredients: | 7 |
NDAs: | 7 |
Patent Litigation for Hec Pharm: | See patent lawsuits for Hec Pharm |
Drugs and US Patents for Hec Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hec Pharm | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 208146-001 | Jul 2, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hec Pharm | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 208146-003 | Jul 2, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hec Pharm Co Ltd | FINGOLIMOD HYDROCHLORIDE | fingolimod hydrochloride | CAPSULE;ORAL | 207939-001 | Nov 10, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hec Pharm | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 207265-001 | May 18, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hec Pharm | ZIDOVUDINE | zidovudine | TABLET;ORAL | 202058-001 | Oct 7, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hec Pharm | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 203584-002 | Sep 28, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hec Pharm | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 204968-001 | Feb 5, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.